These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4015077)

  • 1. Risk factors of ventricular fibrillation during rapid amphotericin B infusion.
    Craven PC; Gremillion DH
    Antimicrob Agents Chemother; 1985 May; 27(5):868-71. PubMed ID: 4015077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of rapid intravenous infusion on serum concentrations of amphotericin B.
    Fields BT; Bates JH; Abernathy RS
    Appl Microbiol; 1971 Oct; 22(4):615-7. PubMed ID: 5130433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid intravenous infusion of amphotericin B: a pilot study.
    Cruz JM; Peacock JE; Loomer L; Holder LW; Evans GW; Powell BL; Lyerly ES; Capizzi RL
    Am J Med; 1992 Aug; 93(2):123-30. PubMed ID: 1497007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of ventricular dysrhythmias during 1-hour infusions of amphotericin B in patients with preserved renal function.
    Bowler WA; Weiss PJ; Hill HE; Hoffmeister KA; Fleck RP; Blacky AR; Oldfield EC
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2542-3. PubMed ID: 1489202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperkalemia associated with rapid infusion of conventional and lipid complex formulations of amphotericin B.
    Barcia JP
    Pharmacotherapy; 1998; 18(4):874-6. PubMed ID: 9692667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient asystole associated with amphotericin B infusion.
    DeMonaco HJ; McGovern B
    Drug Intell Clin Pharm; 1983; 17(7-8):547-8. PubMed ID: 6347598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-insulin infusion for the early treatment of non-oliguric hyperkalemia in extremely-low-birth-weight infants.
    Hung KC; Su BH; Lin TW; Peng CT; Tsai CH
    Acta Paediatr Taiwan; 2001; 42(5):282-6. PubMed ID: 11729704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradialytic administration of amphotericin B: clinical observations on efficacy and safety.
    Wood JE; Mahnensmith MP; Mahnensmith RL; Perazella MA
    Am J Med Sci; 2004 Jan; 327(1):5-8. PubMed ID: 14722389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid infusion of amphotericin B in dextrose.
    Gales MA; Gales BJ
    Ann Pharmacother; 1995 May; 29(5):523-9. PubMed ID: 7655137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular arrhythmias with conventional and liposomal amphotericin.
    Aguado JM; Hidalgo M; Moya I; Alcazar JM; Jimenez MJ; Noriega AR
    Lancet; 1993 Nov; 342(8881):1239. PubMed ID: 7901556
    [No Abstract]   [Full Text] [Related]  

  • 11. Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: A retrospective analysis.
    Yamazaki H; Kondo T; Aoki K; Yamashita K; Takaori-Kondo A
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):123-131. PubMed ID: 29203252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotericin B revisited: reassessment of toxicity.
    Clements JS; Peacock JE
    Am J Med; 1990 May; 88(5N):22N-27N. PubMed ID: 2368770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELECTROCARDIOGRAPHIC AND ELECTROLYTE ABNORMALITIES CAUSED BY AMPHOTERICIN B IN DOG AND MAN.
    BUTLER WT; BENNETT JE; HILL GJ
    Proc Soc Exp Biol Med; 1964; 116():857-63. PubMed ID: 14230372
    [No Abstract]   [Full Text] [Related]  

  • 14. Amphotericin B infusion-related toxicity: comparison of two- and four-hour infusions.
    Nicholl TA; Nimmo CR; Shepherd JD; Phillips P; Jewesson PJ
    Ann Pharmacother; 1995 Nov; 29(11):1081-7. PubMed ID: 8573948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Potassium Dialysate as a Protective Factor of Sudden Cardiac Death in Hemodialysis Patients with Hyperkalemia.
    Huang CW; Lee MJ; Lee PT; Hsu CY; Huang WC; Chen CL; Chou KJ; Fang HC
    PLoS One; 2015; 10(10):e0139886. PubMed ID: 26440515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective investigation on the cases treated with liposomal amphotericin B].
    Yamagishi Y; Mikamo H
    Jpn J Antibiot; 2010 Oct; 63(5):347-64. PubMed ID: 21268407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with community-based amphotericin B infusion therapy.
    Malani PN; Depestel DD; Riddell J; Bickley S; Klein LR; Kauffman CA
    Pharmacotherapy; 2005 May; 25(5):690-7. PubMed ID: 15899731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mannitol on acute amphotericin B nephrotoxicity.
    Said R; Marin P; Anicama H; Quintanilla A; Levin ML
    Res Exp Med (Berl); 1980; 177(2):85-9. PubMed ID: 6777841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.
    Kaisar MO; Wiggins KJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Mudge DW; Bofinger A; Petrie JJ; Johnson DW
    Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.
    Bakris GL; Pitt B; Weir MR; Freeman MW; Mayo MR; Garza D; Stasiv Y; Zawadzki R; Berman L; Bushinsky DA;
    JAMA; 2015 Jul; 314(2):151-61. PubMed ID: 26172895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.